Visão geral da empresa
A deep-tech food company, Steakholder Foods Ltd. is dedicated to developing cultivated meat production technologies within Israel, utilizing advanced machinery such as three-dimensional printers to manufacture meat, fish, and seafood analogs alongside hybrid cultivated meat products. The firm operates within the Consumer Defensive sector, specifically categorized under the Packaged Foods industry, a classification that typically denotes companies producing essential goods with relatively stable demand patterns, though this specific entity focuses on emerging alternative protein manufacturing. As of the latest data, the company maintains a market capitalization of $10.13M, generates annual revenue of $10,000, and employs a workforce of 24 individuals. These valuation and financial scale figures indicate that Steakholder Foods is a micro-cap entity operating with extremely limited revenue generation relative to its market valuation, suggesting a position in the very early stages of commercial viability or a significant disconnect between current operational output and market pricing expectations for its technology assets.
Saúde financeira
The company reported a TTM revenue of $10,000 against a net income loss of $-8,030,000 and an EBITDA of $-7,031,000, revealing a severe structural deficit where operating costs and expenses drastically exceed the nominal revenue generated. This massive gap between the minimal $10,000 revenue and the $-8,030,000 net income highlights an unsustainable cost structure where the company is burning through capital without achieving commercial break-even points. Free cash flow stands at $-5,653,750, which indicates that the company is consuming its available cash reserves to fund operations and research rather than generating liquidity for shareholder returns or debt servicing. The gross margin is reported at -120.0%, the operating margin at -77510.0%, and the profit margin at 0.0%, figures that collectively demonstrate that the cost of goods sold and operating expenses are exponentially higher than the sales volume, resulting in a negative contribution to profitability across all levels of the income statement. On the balance sheet, the company holds $1.43M in cash while carrying $874,000 in debt, with a debt-to-equity ratio of 21.26, suggesting a highly leveraged position relative to equity where liabilities significantly outweigh the book value of shareholder investments. The current ratio is 2.42, which theoretically indicates a level of short-term liquidity where current assets are 2.42 times current liabilities, yet this metric is rendered less meaningful given the absolute scale of negative earnings and cash burn. Return on Equity is -135.2% and Return on Assets is -53.8%, metrics that reveal management is currently unable to generate any positive return on the capital deployed by shareholders or assets held, reflecting the high-risk nature of the venture capital stage of the business.
Avaliação de valorização
The trailing P/E ratio and forward P/E ratio are both listed as N/A, which implies that because the company has no positive earnings, these traditional multiple-based valuation metrics cannot be calculated, thereby preventing any standard comparison of earnings trajectory or future profitability expectations based on price-to-earnings logic. The price-to-book ratio is 410.00, an exceptionally high figure that indicates the market is valuing the company at 410 times its book value, suggesting a massive premium placed on the company's intangible assets, technology, and future growth potential rather than its current tangible net worth. The price-to-sales ratio is 1013.17 and the EV/EBITDA is -213.51, alternative metrics that suggest the market is pricing the stock based on speculative future revenue potential rather than current sales or cash flow performance, highlighting a valuation disconnected from present-day operational realities. The 52-week high is $38.00 and the 52-week low is $1.12, meaning the current price sits at the extreme lower bound of its trading range, specifically trading at approximately 97.07% below the 52-week high and 100% above the 52-week low if one considers the current price to be near the bottom of the provided range, though the exact current price is not explicitly stated, the spread indicates extreme volatility. The beta value is -15.08, a negative and extreme coefficient that implies the stock's price volatility moves inversely to the broader market with a magnitude far exceeding typical equities, making it a highly speculative instrument that does not correlate with general market trends.
Growth & Income
Revenue growth and earnings growth rates are both listed as N/A, indicating that there is insufficient historical data or consistent growth trajectory to calculate year-over-year percentages, which prevents a clear assessment of whether earnings are growing faster or slower than revenue. Since the company does not pay dividends, the dividend yield is N/A and the payout ratio is 0.0%, meaning the company reinvests all available resources, including its limited cash flow, back into its R&D and technology development rather than distributing income to shareholders. The overall growth and income profile is characterized by a complete absence of current profitability or dividend income, with the company relying entirely on external capital formation to sustain operations and pursue its deep-tech manufacturing goals.